Immunity, ISSN 1074-7613, 06/2018, Volume 48, Issue 6, pp. 1061 - 1062
Sporozoites are the malaria parasite life-cycle stage that is transmitted to humans, mice, and other hosts by mosquitoes. [...]publication of the 1967 paper,...
Medicine | Proteins | Leadership | Parasitology | Malaria | Clinical trials | Aquatic insects | Tropical diseases
Medicine | Proteins | Leadership | Parasitology | Malaria | Clinical trials | Aquatic insects | Tropical diseases
Journal Article
Science, ISSN 0036-8075, 9/2013, Volume 341, Issue 6152, pp. 1359 - 1365
Consistent high-level, vaccine-induced protection against human malaria has only been achieved by inoculation of Plasmodium falciparum (Pf) sporozoites (SPZ)...
T lymphocytes | Antigens | Patents | Immunization | RESEARCH ARTICLE | Malaria | Intravenous injections | Vaccination | Sporozoites | Antibodies | Dosage | ANTIBODIES | TRIAL | IMMUNITY | CD8+ T-CELLS | EFFICACY | LIVER STAGES | MULTIDISCIPLINARY SCIENCES | MICE | PLASMODIUM-FALCIPARUM MALARIA | CIRCUMSPOROZOITE PROTEIN VACCINE | Malaria, Falciparum - prevention & control | Humans | Male | Plasmodium falciparum - immunology | Vaccination - adverse effects | Sporozoites - immunology | Administration, Intravenous | Animals | Malaria Vaccines - administration & dosage | Vaccination - methods | Malaria Vaccines - adverse effects | Malaria Vaccines - immunology | Adult | Female | T-Lymphocytes - immunology | Mice | Immunity, Cellular | Cytokines - immunology | Prevention | Intravenous therapy | Sporozoa | Health aspects | Risk factors | Methods | Monoclonal antibodies | Vaccines | Immune system | Medical research | Cellular | Correlation | Attenuation | Parasites
T lymphocytes | Antigens | Patents | Immunization | RESEARCH ARTICLE | Malaria | Intravenous injections | Vaccination | Sporozoites | Antibodies | Dosage | ANTIBODIES | TRIAL | IMMUNITY | CD8+ T-CELLS | EFFICACY | LIVER STAGES | MULTIDISCIPLINARY SCIENCES | MICE | PLASMODIUM-FALCIPARUM MALARIA | CIRCUMSPOROZOITE PROTEIN VACCINE | Malaria, Falciparum - prevention & control | Humans | Male | Plasmodium falciparum - immunology | Vaccination - adverse effects | Sporozoites - immunology | Administration, Intravenous | Animals | Malaria Vaccines - administration & dosage | Vaccination - methods | Malaria Vaccines - adverse effects | Malaria Vaccines - immunology | Adult | Female | T-Lymphocytes - immunology | Mice | Immunity, Cellular | Cytokines - immunology | Prevention | Intravenous therapy | Sporozoa | Health aspects | Risk factors | Methods | Monoclonal antibodies | Vaccines | Immune system | Medical research | Cellular | Correlation | Attenuation | Parasites
Journal Article
1996, ISBN 9781555811112, x, 310
Book
Journal of Cardiac Failure, ISSN 1071-9164, 11/2018, Volume 24, Issue 11, pp. 813 - 813
Transthyretin cardiomyopathy (ATTR-CM) is an underdiagnosed, fatal disease caused by the deposition of transthyretin amyloid fibrils in the heart leading to...
Cardiomyopathy | Heart diseases | Analysis
Cardiomyopathy | Heart diseases | Analysis
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue Suppl 4, pp. D13 - D23
Abstract In 2013 there were an estimated 584,000 deaths and 198 million clinical illnesses due to malaria, the majority in sub-Saharan Africa. Vaccines would...
Allergy and Immunology | Plasmodium falciparum | Malaria vaccines | Malaria elimination | Malaria | Vaccine | Plasmodium falciparum vaccines | Malaria prevention | DIRECT VENOUS INOCULATION | LISTERIA-MONOCYTOGENES | MEDICINE, RESEARCH & EXPERIMENTAL | T-CELL IMMUNITY | PLASMODIUM-FALCIPARUM SPOROZOITES | INTRADERMAL INJECTION | IMMUNOLOGY | TRANSMISSION-BLOCKING VACCINE | SEQUENTIAL IMMUNIZATION | ANTIBODY-RESPONSES | MONOCLONAL-ANTIBODIES | CIRCUMSPOROZOITE PROTEIN VACCINE | Plasmodium vivax - growth & development | Disease Eradication | Malaria, Falciparum - prevention & control | Malaria, Vivax - parasitology | Humans | Plasmodium vivax - genetics | Plasmodium falciparum - immunology | Recombinant Proteins | Plasmodium vivax - immunology | Sporozoites - immunology | Life Cycle Stages | Malaria, Falciparum - parasitology | Clinical Trials, Phase III as Topic | Animals | Plasmodium falciparum - genetics | Malaria Vaccines - immunology | Malaria, Falciparum - immunology | Malaria, Vivax - immunology | Malaria, Vivax - prevention & control | Plasmodium falciparum - growth & development | Immunity, Cellular | Prevention | Malaria vaccine | Bacteria | Vaccines | Health aspects | Recombinant proteins | Antigens | Anopheles | Parasitic diseases | Mosquitoes | Parasites | Mortality
Allergy and Immunology | Plasmodium falciparum | Malaria vaccines | Malaria elimination | Malaria | Vaccine | Plasmodium falciparum vaccines | Malaria prevention | DIRECT VENOUS INOCULATION | LISTERIA-MONOCYTOGENES | MEDICINE, RESEARCH & EXPERIMENTAL | T-CELL IMMUNITY | PLASMODIUM-FALCIPARUM SPOROZOITES | INTRADERMAL INJECTION | IMMUNOLOGY | TRANSMISSION-BLOCKING VACCINE | SEQUENTIAL IMMUNIZATION | ANTIBODY-RESPONSES | MONOCLONAL-ANTIBODIES | CIRCUMSPOROZOITE PROTEIN VACCINE | Plasmodium vivax - growth & development | Disease Eradication | Malaria, Falciparum - prevention & control | Malaria, Vivax - parasitology | Humans | Plasmodium vivax - genetics | Plasmodium falciparum - immunology | Recombinant Proteins | Plasmodium vivax - immunology | Sporozoites - immunology | Life Cycle Stages | Malaria, Falciparum - parasitology | Clinical Trials, Phase III as Topic | Animals | Plasmodium falciparum - genetics | Malaria Vaccines - immunology | Malaria, Falciparum - immunology | Malaria, Vivax - immunology | Malaria, Vivax - prevention & control | Plasmodium falciparum - growth & development | Immunity, Cellular | Prevention | Malaria vaccine | Bacteria | Vaccines | Health aspects | Recombinant proteins | Antigens | Anopheles | Parasitic diseases | Mosquitoes | Parasites | Mortality
Journal Article
Malaria Journal, ISSN 1475-2875, 10/2012, Volume 11, Issue S1, pp. O48 - O48
Journal Article
Nature, ISSN 0028-0836, 02/2017, Volume 542, Issue 7642, pp. 445 - 449
A highly protective malaria vaccine would greatly facilitate the prevention and elimination of malaria and containment of drug-resistant parasites(1). A high...
DIRECT VENOUS INOCULATION | ANTIBODIES | LIVER-STAGE | IMMUNIZATION | IMMUNITY | CD8+ T-CELLS | MULTIDISCIPLINARY SCIENCES | PLASMODIUM-FALCIPARUM SPOROZOITES | CHLOROQUINE PROPHYLAXIS | INFECTION | HUMAN VOLUNTEERS | Malaria, Falciparum - prevention & control | Double-Blind Method | Antibodies, Protozoan - immunology | Humans | Middle Aged | Chloroquine - therapeutic use | Plasmodium falciparum - immunology | Healthy Volunteers | Sporozoites - immunology | Young Adult | Malaria, Falciparum - blood | Malaria, Falciparum - parasitology | Antibodies, Protozoan - blood | Vaccines, Attenuated - immunology | Malaria Vaccines - administration & dosage | Plasmodium falciparum - classification | Time Factors | Vaccines, Attenuated - administration & dosage | Adolescent | Malaria Vaccines - immunology | Malaria, Falciparum - immunology | Adult | T-Lymphocytes - immunology | Immunologic Memory - immunology | Prevention | Dosage and administration | Malaria | Malaria vaccine | Proteins | Automation | Immunoglobulins | Mosquitoes | Lymphocytes | Liver | Infections | Parasites | Vaccines | Drug dosages
DIRECT VENOUS INOCULATION | ANTIBODIES | LIVER-STAGE | IMMUNIZATION | IMMUNITY | CD8+ T-CELLS | MULTIDISCIPLINARY SCIENCES | PLASMODIUM-FALCIPARUM SPOROZOITES | CHLOROQUINE PROPHYLAXIS | INFECTION | HUMAN VOLUNTEERS | Malaria, Falciparum - prevention & control | Double-Blind Method | Antibodies, Protozoan - immunology | Humans | Middle Aged | Chloroquine - therapeutic use | Plasmodium falciparum - immunology | Healthy Volunteers | Sporozoites - immunology | Young Adult | Malaria, Falciparum - blood | Malaria, Falciparum - parasitology | Antibodies, Protozoan - blood | Vaccines, Attenuated - immunology | Malaria Vaccines - administration & dosage | Plasmodium falciparum - classification | Time Factors | Vaccines, Attenuated - administration & dosage | Adolescent | Malaria Vaccines - immunology | Malaria, Falciparum - immunology | Adult | T-Lymphocytes - immunology | Immunologic Memory - immunology | Prevention | Dosage and administration | Malaria | Malaria vaccine | Proteins | Automation | Immunoglobulins | Mosquitoes | Lymphocytes | Liver | Infections | Parasites | Vaccines | Drug dosages
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 11/2011, Volume 108, Issue 47, pp. E1214 - E1223
Clinical studies and mathematical models predict that, to achieve malaria elimination, combination therapies will need to incorporate drugs that block the...
CONTROLLED-TRIAL | MOSQUITOS | VIVAX | MULTIDISCIPLINARY SCIENCES | transfection | COMBINATION | GAMETOCYTES | PHARMACOKINETICS | artemisinin-based combination therapies | MALARIA | EXPRESSION | PRIMAQUINE | ARTESUNATE | Quinolines | Blotting, Southern | Germ Cells, Plant - drug effects | Green Fluorescent Proteins | Naphthyridines | Fluorenes | Plasmodium falciparum - drug effects | Ethanolamines | Methylene Blue - pharmacology | Antimalarials - pharmacology | Dose-Response Relationship, Drug | Amodiaquine - analogs & derivatives | Animals | Artemisinins | Luciferases | Sexual Development - physiology | Anopheles - microbiology | Malaria - transmission | Plasmodium falciparum - physiology | Genetic Vectors | Biological Sciences | PNAS Plus
CONTROLLED-TRIAL | MOSQUITOS | VIVAX | MULTIDISCIPLINARY SCIENCES | transfection | COMBINATION | GAMETOCYTES | PHARMACOKINETICS | artemisinin-based combination therapies | MALARIA | EXPRESSION | PRIMAQUINE | ARTESUNATE | Quinolines | Blotting, Southern | Germ Cells, Plant - drug effects | Green Fluorescent Proteins | Naphthyridines | Fluorenes | Plasmodium falciparum - drug effects | Ethanolamines | Methylene Blue - pharmacology | Antimalarials - pharmacology | Dose-Response Relationship, Drug | Amodiaquine - analogs & derivatives | Animals | Artemisinins | Luciferases | Sexual Development - physiology | Anopheles - microbiology | Malaria - transmission | Plasmodium falciparum - physiology | Genetic Vectors | Biological Sciences | PNAS Plus
Journal Article
Nature, ISSN 0028-0836, 12/2006, Volume 444, Issue 7121, pp. 824 - 827
The infectious form of the malaria parasite has thousands of proteins, making it tough to develop a vaccine for it. Narrowing down which proteins cause...
IMMUNIZATION | GENOMICS | EFFICACY | SAFETY | MULTIDISCIPLINARY SCIENCES | PLASMODIUM-FALCIPARUM SPOROZOITES | VACCINE | Immunodominant Epitopes - immunology | Antigens, Protozoan - immunology | Humans | Malaria - immunology | Sporozoites - immunology | Malaria Vaccines - chemistry | Malaria - prevention & control | Sporozoites - chemistry | Immunodominant Epitopes - administration & dosage | Animals | Malaria Vaccines - administration & dosage | Antigens, Protozoan - administration & dosage | Malaria - parasitology | Malaria Vaccines - immunology | Mice | Protozoan Proteins - administration & dosage | Protozoan Proteins - immunology | Proteins | Pharmacology | Immunology | Vaccines | Malaria
IMMUNIZATION | GENOMICS | EFFICACY | SAFETY | MULTIDISCIPLINARY SCIENCES | PLASMODIUM-FALCIPARUM SPOROZOITES | VACCINE | Immunodominant Epitopes - immunology | Antigens, Protozoan - immunology | Humans | Malaria - immunology | Sporozoites - immunology | Malaria Vaccines - chemistry | Malaria - prevention & control | Sporozoites - chemistry | Immunodominant Epitopes - administration & dosage | Animals | Malaria Vaccines - administration & dosage | Antigens, Protozoan - administration & dosage | Malaria - parasitology | Malaria Vaccines - immunology | Mice | Protozoan Proteins - administration & dosage | Protozoan Proteins - immunology | Proteins | Pharmacology | Immunology | Vaccines | Malaria
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 498 - 509
Summary Background Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria sporozoite vaccine that has been...
Infectious Disease | IMMUNIZATION | IMMUNITY | INFECTIOUS DISEASES | PROTECTION | MEMORY | NONREPLICATING SPOROZOITE VACCINE | GAMBIA | MEN | HUMANS | Malaria, Falciparum - prevention & control | Double-Blind Method | Humans | Fluorenes - therapeutic use | Artemisinins - administration & dosage | Male | Antimalarials - therapeutic use | Plasmodium falciparum - immunology | Ethanolamines - administration & dosage | Artemisinins - therapeutic use | Vaccination - methods | Antimalarials - administration & dosage | Mali | Adolescent | Adult | Ethanolamines - therapeutic use | Female | Fluorenes - administration & dosage | Immunization Schedule | Plasmodium falciparum | Medical research | Malaria | Parasitic diseases | Clinical trials | Medicine, Experimental | Product development | Adults | Vaccines | Analysis | Vaccination | Biometrics | Asymptotic properties | Toxicity | Antibodies | Bites | Homology | Infections | Parasites | Developing countries--LDCs | Antibody response | Incidence | Hepatitis | Towns | Alignment | Cryopreservation | Syphilis | Human immunodeficiency virus--HIV | Attenuation | Libraries | Masking | Safety | Drug dosages | Age | Circumsporozoite protein | EKG | Antigens | Hum | Immunological memory | Effectiveness | Review boards | Abnormalities | Hypersensitivity | BCG | Contraception | Exposure | Vectors | Appendix | Pregnancy | Disease transmission | Infectious diseases | Immunogenicity | Artemether | Added value | Differentiation
Infectious Disease | IMMUNIZATION | IMMUNITY | INFECTIOUS DISEASES | PROTECTION | MEMORY | NONREPLICATING SPOROZOITE VACCINE | GAMBIA | MEN | HUMANS | Malaria, Falciparum - prevention & control | Double-Blind Method | Humans | Fluorenes - therapeutic use | Artemisinins - administration & dosage | Male | Antimalarials - therapeutic use | Plasmodium falciparum - immunology | Ethanolamines - administration & dosage | Artemisinins - therapeutic use | Vaccination - methods | Antimalarials - administration & dosage | Mali | Adolescent | Adult | Ethanolamines - therapeutic use | Female | Fluorenes - administration & dosage | Immunization Schedule | Plasmodium falciparum | Medical research | Malaria | Parasitic diseases | Clinical trials | Medicine, Experimental | Product development | Adults | Vaccines | Analysis | Vaccination | Biometrics | Asymptotic properties | Toxicity | Antibodies | Bites | Homology | Infections | Parasites | Developing countries--LDCs | Antibody response | Incidence | Hepatitis | Towns | Alignment | Cryopreservation | Syphilis | Human immunodeficiency virus--HIV | Attenuation | Libraries | Masking | Safety | Drug dosages | Age | Circumsporozoite protein | EKG | Antigens | Hum | Immunological memory | Effectiveness | Review boards | Abnormalities | Hypersensitivity | BCG | Contraception | Exposure | Vectors | Appendix | Pregnancy | Disease transmission | Infectious diseases | Immunogenicity | Artemether | Added value | Differentiation
Journal Article
11.
Full Text
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
Nature Medicine, ISSN 1078-8956, 06/2016, Volume 22, Issue 6, pp. 614 - 623
An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection (CHMI) 3...
MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | DELTA T-CELLS | ELIMINATION | PLASMODIUM-YOELII | CELL BIOLOGY | SPOROZOITE VACCINE | IMMUNIZATION | INTERFERON | MEMORY | ENHANCEMENT | MICE | MONOCLONAL-ANTIBODIES | Malaria, Falciparum - prevention & control | Humans | Middle Aged | Male | Macaca mulatta | Plasmodium falciparum - immunology | Healthy Volunteers | Sporozoites - immunology | Young Adult | Liver - immunology | Immunoglobulin G - immunology | Malaria Vaccines - immunology | Adult | Female | Malaria Vaccines - therapeutic use | Immunogenicity, Vaccine - immunology | Enzyme-Linked Immunosorbent Assay | Antibodies, Protozoan - immunology | Parasitemia - immunology | Administration, Intravenous | Animals | Interferon-gamma - immunology | Adolescent | Parasitemia - prevention & control | T-Lymphocytes - immunology | Liver - cytology | CD8-Positive T-Lymphocytes - immunology | Prevention | Malaria | Malaria vaccine | Physiological aspects | Causes of | Research | T cells | Vaccines | Immune system
MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | DELTA T-CELLS | ELIMINATION | PLASMODIUM-YOELII | CELL BIOLOGY | SPOROZOITE VACCINE | IMMUNIZATION | INTERFERON | MEMORY | ENHANCEMENT | MICE | MONOCLONAL-ANTIBODIES | Malaria, Falciparum - prevention & control | Humans | Middle Aged | Male | Macaca mulatta | Plasmodium falciparum - immunology | Healthy Volunteers | Sporozoites - immunology | Young Adult | Liver - immunology | Immunoglobulin G - immunology | Malaria Vaccines - immunology | Adult | Female | Malaria Vaccines - therapeutic use | Immunogenicity, Vaccine - immunology | Enzyme-Linked Immunosorbent Assay | Antibodies, Protozoan - immunology | Parasitemia - immunology | Administration, Intravenous | Animals | Interferon-gamma - immunology | Adolescent | Parasitemia - prevention & control | T-Lymphocytes - immunology | Liver - cytology | CD8-Positive T-Lymphocytes - immunology | Prevention | Malaria | Malaria vaccine | Physiological aspects | Causes of | Research | T cells | Vaccines | Immune system
Journal Article